Rockleo - that post was almost "Braveheart"-ish. Nicely done.

GLTU/A.

Believe you me when I say we are not alone in this thinking:
" I compare us to many other companies right now it’s bizarre"

It is NOT normal.. (theories or not)

GLTU/A.

JLA - we are definitely oversold. Makes you wonder are there other deep pocket'ed forces at work? Sure there are shorts, but to be this oversold while we're at the precipice of an approval. Hmmmm.......

GLTU/A.

So, another one bites the dust. This time a MAB. Shocking... (pun)

GLTU/A.

Thanks for posting, Angryman. Link below:

https://twitter.com/TomLandstreet/status/1321893434639192066

GLTU/A.

Agree it's aggressive, but so is this pandemic and it doesn't show like it's letting up anytime in the near future (which is probably why it's priced that way [FPE]).

GLTU/A.

Looking at what GILD was scheduled to receive for Rem ($3bb) and we were to assume $2B using GILD's FPE, this puts a price of CYDY well over the $100 range. That's including GILD's overhead, RE costs, other expenses. Just need that 1st domino to fall. TNBC, Nash, HIV isn't even priced in.
As BlackOps says, big picture.
One step at a time. Lets break that $10 mark first, then we can talk about leaning on the BOD to start buybacks.

Lets see what Christmas this year has in store for CYDY.

GLTU/A.

All the best Jay. This thing can't get approval fast enough and off-labal usage. Hang in there, it will come (both financially and health-wise!).

Stay safe.

GLTU/A.

That's a lot of money to throw down the toilet.
At least the fish will be a bit more tasty.

GLTU/A.

That would 'infer' Smiley blinks and the last I remember, he doesn't have eyelids as NP says DON'T BLINK

Thanks for coming back and posting in a minute.

GLTU/A.

Chuckles759 - are you still holding on to the mic or have you dropped it after the rheumatologist breakdown to parts and context for our new CSO and recent new hire, Mahboob?

GLTU/A. DON'T BLINK

We'll get ours, they'll get theirs.
Thanks for posting that jakeflies.

GLTU/A.

Thanks, I checked 2 sites off google and was manually adding. Didn't realize he had that many! Even more so, leans towards my initial and your theory regarding de-risking due to potential tax changes. Cheers.

GLTU/A.

Apparently they hit PE and SE with 775 patients according to their PR. I guess with some $ and an N high enough one could probably hit both as long as you have the money, time and a choice to which ends to hit.

Plenty of room for therapeutics but good for them.

GLTU/A.

nt2innovate - that was exactly my point.
Question: where are you seeing 12mm? I only counted near 6mm.

GLTU/A.

He should have sold all of his 6mm shares he's holding as he's not an insider anymore and he thinks this is going to tank. He's selling 15% of his holdings. Current cap gain is 15%. We have an election coming with potential dramatic tax changes. Locking in profits? Maybe. Makes sense to me, especially now he's not on the BOD.

Thanks for posting this jeromefrommanhattan.

GLTU/A.

Although they are all very very similar here's a new site for the Philippines:

https://thephilbiznews.com/chiral-pharma-cytodyn-inc-partner-to-secure-covid-19-drug-fda-approval/

GLTU/A.

I don't know if he's a very good Dr or not, but for every quarterback (BP) there needs a cheerleader(YO).

Maraviroc I've read doesn't play nice on the liver and doesn't promote CD8(?) cells. Yeah, it's 'cheaper' but how do you put a price on your own life?

GLTU/A.

Let's see:

The only company without PE change for Phase 3 Severe/Critical. Check.
The only company that has weekly injections mono therapy. Check.
The only company that has therapy for long haulers. Check.

Future prospects looking pretty good.

GLTU/A.

This link will work:
https://us.newschant.com/health/some-covid-survivors-have-antibodies-that-attack-the-body-not-virus/

GLTU/A.

A small snowball rolling down the hill can/will cause an avalanche.
$0.20 today, $X in a few weeks. $XX in a few months etc.

Can't stop this avalanche. One must just enjoy the beauty of that is nature(well science in our case).

GLTU/A. DON'T BLINK Unless you have a ton of shares and you good.

Whosonfirst - your optimism only rivals Monroe1's on this board.
Glass is 3/4 full for you, sir.

GLTU/A. DON'T BLINK

Checking both you sent me Monroe1, thanks very much.

GLTU/A.

Does anyone know of a company that had their drug approved by EU first (and how long did that take?) and then eventually the FDA?

GLTU/A.

Looks like we held the $2.25 support yesterday (from 4/17), which is a great sign. Need to close above previous support of $2.68 and go onward and upwards from there.

Spidey senses tell me we will get news +/- 1 day, next week on election day.

GLTU/A. DONT BLINK

Anyone else notice that the trial enrollment on the EU side for this says 290 vs the 390 in the US? Food for thought, eh?
I found it VERY interesting..........

GLTU/A. DON'T BLINK

Actually - this is not uncommon. A lot of algo's use 'sentiment' to project out pricing, depending on which ML you use and which indicators you use to weight more on. For example, 9EMA, 20EMA + sentiment you'll use more recent activity vs 50, 120 MA. Definitely not uncommon.

NOTE: it is a projection and that's all it is. You definitely CAN'T time PR's/catalyst's to a date and time! If one could they well, you know the rest.

GLTU/A. DON'T BLINK

https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001996-33/GB#G

GLTU/A

@Lawman --
Awesome post and 100% agree as I've stated to him and sent him an email when we started the pandemic. Please send an email (npourhassan@cytodyn.com) directly as well, if not already.

GLTU/A.

100% agree with you. There's been a ton of consolidation.

GLTU/A.

Would NOT surprise me a buyout offer or hostile T/O if the price keeps dropping.. IMO.

Either way this product needs to get out there ASAP. I myself would like a yearly shot of this drug to calm inflammation.

GLTU/A.

Great post Grip and from the heart. Thanks, much appreciated.
Yeah this stock is a quirky little stock with fundamentals that are bar none. I can't comment on NP to the extent you have as my experience with him is limited. Thanks for the good thoughts and I think all of us can benefit with this molecule getting out there in the world!

GLTU/A.

Saltz - you have his vernacular down to a 'T'
"SP should be triple digits w such beautiful fantastic news "
That actually made me LOL. Thanks for that.

GLTU/A.

It's been 14 since 2 weeks ago and 15 recently:
https://clinicaltrials.gov/ct2/history/NCT04347239?A=11&B=11&C=merged#StudyPageTop

Keep an eye on that for potential UK hospitals to enroll.
Perhaps some in the midwest.

GLTU/A.

I've done my part as I've already sent them that recommendation. For others that have some correspondence with the BOD and crew, please oblige!

GLTU/A.

I admit I said good bye to the 3's. I never gave a timeframe (following NP's foot steps). Take advantage while you can. One can only wish they had more $$ to snap these up at these delicious prices. We will say goodbye, but house guest is sticking around for a bit..

BTW - who does Folgers anymore, keep it old school: Sanka.

GLTU/A.

Grip - you may just get your wish of $2.00 if we don't hold support of $2.25 (4/17/20). Let's see what NP has in store for us this week.

GLTU/A.

DON'T BLINK </br>

I'm in this for the long haul and have been for the past 6 months. Lets call it for what it is, it's definitely desperation.
That being said, NP does like to be transparent but I doubt this news will have any effect on SP. May have been better to have added the current count of patients currently enrolled in CD12. Now, that's news worthy AND being transparent.

GLTU/A.

Great minds think a like, only difference here is that I drink my first cup of joe and prime myself for the daily amusing short/bash talk..

GLTU/A.

"Pay to enroll the 63 and do it now!" -- has anyone suggested this to NP/SK that have their ears? This can probably enroll in 2 weeks if the case and money is right.

GLTU/A.